Dev Chemicals & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 03-01-2025
- Paid Up Capital ₹ 3.63 M
as on 03-01-2025
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 8.43%
(FY 2020)
- Profit -3.46%
(FY 2020)
- Ebitda -0.49%
(FY 2020)
- Net Worth 5.19%
(FY 2020)
- Total Assets 0.41%
(FY 2020)
About Dev Chemicals & Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.63 M, as per Ministry of Corporate Affairs (MCA) records.
Kantilal Jain and Nirmala Jain serve as directors at the Company.
- CIN/LLPIN
U93090TN1995PTC030750
- Company No.
030750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1995
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dev Chemicals & Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kantilal Jain  | Director | 10-Apr-2006 | Current |
| Nirmala Jain | Director | 11-Dec-2010 | Current |
Financial Performance of Dev Chemicals & Pharmaceuticals.
Dev Chemicals & Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 8.43% increase. The company also saw a slight decrease in profitability, with a 3.46% decrease in profit. The company's net worth moved up by a moderate rise of 5.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dev Chemicals & Pharmaceuticals?
In 2020, Dev Chemicals & Pharmaceuticals had a promoter holding of 91.88% and a public holding of 8.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dev Chemicals & Pharmaceuticals?
Unlock and access historical data on people associated with Dev Chemicals & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dev Chemicals & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Chemicals & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
